Anti-Human CD52 Recombinant Antibody(Tarextumab)

Product Information

Catalog Number	YR1312
Product Name	Anti-Human CD52 Recombinant Antibody(Tarextumab)
Molecular Name	Tarextumab
Alias	Anti-CD52 Recombinant Antibody, Research Grade Tarextumab
CAS Number	1359940-55-8
Target	CD52[Homo sapiens]
Isotype	IgG2 Kappa Lambda
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	IF, IP, Neut, FuncS, ELISA, FCM
Buffer	PBS, pH7.5
Background	Tarextumab (formerly OMP-59R5) is a fully human monoclonal antibody targeting the Notch 2/3 receptors. It is being tested as a possible treatment for cancer. In January 2015, the US FDA granted orphan drug designation to tarextumab for the treatment of pancreatic cancer and lung cancer. Two early stage clinical trials have reported encouraging results.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price